N. A. Elemessova

N. A. Elemessova

Auto-generated profile, based on publicly available information

N. A. Elemessova

“Center of Nuclear Medicine and Oncology” of Abay Regional Health Department

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 April 2026 in NNC RK Bulletin
Verified
Journal Article
Closed access
AMA. D. Mergenbayeva
A. D. Mergenbayeva
STS. Z. Tanatarov
S. Z. Tanatarov
MIM. T. Idinov
M. T. Idinov
LKLaura B Kenzhina
Laura B Kenzhina
BAB. Zh. Atantayeva
B. Zh. Atantayeva
ESE. O. Sabekov
E. O. Sabekov
The study was conducted at the Center of Nuclear Medicine and Oncology (Semey) and is devoted to a comparative dosimetric analysis of external beam radiotherapy planning parameters for locally advanced cervical cancer. Three- dimensional conformal radiotherapy (3D-CRT), intensity-modulated radiation therapy (IMRT), and volumetric modulated arc therapy (VMAT) were compared in terms of dose distribution quality and dose burden to organs at risk. Treatment planning was performed for 25 patients using a TrueBeam linear accelerator with daily patient setup verification based on IGRT/CBCT. Plan quality was evaluated using dose–volume histograms, including D95% for the planning target volume (PTV), conformity index (CI) and homogeneity index (HI), as well as absolute dose parameters (Dmean, Dmax) for organs at risk, in accordance with RTOG criteria and QUANTEC recommendations. The analysis demonstrated that VMAT provided the most favorable dosimetric performance, with a high conformity index (CI = 1,03±0,02) and a low homogeneity index (HI = 0,09±0,02), ensuring more uniform and accurate PTV coverage compared with IMRT and 3D-CRT. A key finding was a substantial reduction in dose burden to pelvic organs at risk: VMAT resulted in an average 25–30% reduction in overall dose compared with 3D-CRT, while the mean dose to the rectum (Dmean) decreased to 33,0 Gy. In addition, VMAT significantly reduced the average treatment delivery time to 5–7 minutes, thereby lowering the risk of intrafraction motion. The obtained results confirm the dosimetric advantages of VMAT and substantiate its feasibility for routine clinical use in a regional oncology center.

25 April 2026 in NNC RK Bulletin
Verified
Journal Article
Closed access
NEN. A. Elemessova
N. A. Elemessova
STS. Z. Tanatarov
S. Z. Tanatarov
MIM. T. Idinov
M. T. Idinov
LKLaura B Kenzhina
Laura B Kenzhina
BAB. Zh. Atantayeva
B. Zh. Atantayeva
NKN. Yu. Karnakova
N. Yu. Karnakova
The study was conducted at the Center of Nuclear Medicine and Oncology of the Abai Region (Semey, Kazakhstan) and was aimed at the quantitative evaluation and optimization of dose planning parameters in patients with head and neck tumors. A retrospective analysis included seven patients (N = 7) treated in 2024, for whom radiotherapy plans were generated using intensity-modulated radiation therapy (Intensity-Modulated Radiation Therapy, IMRT) and volumetric modulated arc therapy (Volumetric Modulated Arc Therapy, VMAT) on a TrueBeam linear accelerator within the Eclipse treatment planning system. The objective of the study was a comparative physical-dosimetric assessment of plan quality with analysis of key dosimetric metrics and logistical efficiency of dose delivery. The analysis demonstrated comparable coverage of the planning target volume (PTV) for both techniques, while clinically significant differences were observed in dose distribution to organs at risk. The use of VMAT resulted in a reduction of the mean dose to the parotid glands by 4,65 Gy compared with IMRT (19,60±7,97 Gy vs. 24,26±3,75 Gy), achieving values below the critical threshold of 25 Gy and contributing to preservation of glandular function. The mean dose to the spinal cord was also lower with VMAT (37,96±4,16 Gy vs. 41,37±1,94 Gy), thereby enhancing radiation safety of treatment. Logistical analysis revealed a clear advantage of VMAT, characterized by more than a 60% reduction in monitor units and dose delivery time compared with IMRT, which contributes to decreased radiation exposure of organs at risk and supports the feasibility of VMAT as a preferred technique in routine clinical practice.

25 April 2026 in NNC RK Bulletin
Verified
Journal Article
Closed access
ATA. D. Tussupova
A. D. Tussupova
SAS. M. Aitkaliyev
S. M. Aitkaliyev
ZAZh. K. Aitkaliyev
Zh. K. Aitkaliyev
MIM. T. Idinov
M. T. Idinov
STS. Z. Tanatarov
S. Z. Tanatarov
AEA. K. Essengari
A. K. Essengari
This study presents a retrospective physico-dosimetric analysis of differences between two-dimensional (2D) and three-dimensional (3D) treatment planning approaches in high-dose-rate (HDR) brachytherapy for 20 patients with locally advanced cervical cancer. The research was conducted at the Center for Nuclear Medicine and Oncology of the Abai Region between 2023 and 2025 and included two independent cohorts of 10 treatment plans each, generated using the GammaMed Plus iX after loading system and the BrachyVision treatment planning software. A key methodological feature of the study was the use of a dedicated CT topometric provider table, enabling indexed patient positioning and eliminating geometric uncertainties during preparation for 3D treatment planning. The aim of the study was to quantitatively assess differences in clinical target volume coverage and dose exposure to organs at risk during the transition to 3D planning. To ensure methodological comparability, in accordance with GEC-ESTRO recommendations and ICRU Report 89, retrospective contouring of the high-risk clinical target volume (HR-CTV) and organs at risk (OARs) was performed on archived CT images for the 10 plans in the 2D cohort, followed by recalculation of volumetric dosimetric parameters. The primary dosimetric endpoints included HR-CTV D90 and OAR D2cc for the bladder, rectum, and sigmoid colon. Statistical analysis of independent samples demonstrated that 3D planning, supported by precise target fixation, is associated with reduced variability of HR-CTV D90, improved dose distribution conformity, and the ability to accurately assess volumetric dose exposure to organs at risk. The obtained results are consistent with international guidelines and highlight the advantages of three-dimensional planning in improving the accuracy, quality, and safety of brachytherapy in oncological practice in Kazakhstan.